secwatch.observer — SEC 8-K summary
======================================

Issuer:     bioAffinity Technologies, Inc. (BIAF)
CIK:        0001712762
Form:       8-K
Filed at:   2025-12-22T23:59:59+00:00
Accession:  0001493152-25-028809
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Dr. Joyce transfers Village Oaks Pathology equity to Dr. Humphreys; new succession agreement executed
--------------------------------------------------------------------------------

- Dr. Joyce (77) informed Company of desire to transfer 100% stock of Village Oaks Pathology to Dr. Humphreys; not due to disagreement.
- On Dec 22, 2025, Village Oaks Pathology, PPLS, and Dr. Humphreys entered a Succession Agreement restricting disposal of equity.
- Agreement provides for automatic transfer of equity to a successor upon death, disability, retirement, incompetence, or failure to meet eligibility requirements.
- Dr. Humphreys must use commercially reasonable efforts to preserve Village Oaks Pathology's operations, contracts, and licenses.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1712762/000149315225028809/0001493152-25-028809-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1712762/000149315225028809/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-028809

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer